Details for New Drug Application (NDA): 012813
✉ Email this page to a colleague
The generic ingredient in BLEPHAMIDE is prednisolone acetate; sulfacetamide sodium. There are eighty-eight drug master file entries for this compound. Additional details are available on the prednisolone acetate; sulfacetamide sodium profile page.
Summary for 012813
Tradename: | BLEPHAMIDE |
Applicant: | Allergan |
Ingredient: | prednisolone acetate; sulfacetamide sodium |
Patents: | 0 |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | SUSPENSION;OPHTHALMIC | Strength | 0.2%;10% | ||||
Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | Yes |
Complete Access Available with Subscription